GRAFT POLYMER UK LS -001
Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, which has completed Phase I clinical trial to treat moderate to severe alcohol use disorder. Its pre-cl… Read more
GRAFT POLYMER UK LS -001 (J4I) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, GRAFT POLYMER UK LS -001 (J4I) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
GRAFT POLYMER UK LS -001 - Net Assets Trend (None–None)
This chart illustrates how GRAFT POLYMER UK LS -001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GRAFT POLYMER UK LS -001 (None–None)
The table below shows the annual net assets of GRAFT POLYMER UK LS -001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to GRAFT POLYMER UK LS -001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
GRAFT POLYMER UK LS -001 Competitors by Market Cap
The table below lists competitors of GRAFT POLYMER UK LS -001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CTSUF
PINK:CTSUF
|
$10.00 Million |
|
DEER HORN METS
F:G1J
|
$10.00 Million |
|
QMINES LTD
F:81V
|
$10.01 Million |
|
Cann Group Limited
PINK:CNGGF
|
$10.01 Million |
|
PT Master Print Tbk
JK:PTMR
|
$10.00 Million |
|
Airo Lam limited
NSE:AIROLAM
|
$10.00 Million |
|
Indiana Resources Ltd
AU:IDA
|
$10.00 Million |
|
SOFTOX SOLUTIONS NK 002
F:6FV
|
$10.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GRAFT POLYMER UK LS -001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares GRAFT POLYMER UK LS -001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently GRAFT POLYMER UK LS -001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares GRAFT POLYMER UK LS -001's net assets metrics with peer companies in the Specialty Industrial Machinery industry.
Industry Context
- Industry: Specialty Industrial Machinery
- Average net assets among peers: $7,657,119,913
- Average return on equity (ROE) among peers: -52.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GRAFT POLYMER UK LS -001 (J4I) | €- | N/A | N/A | $10.00 Million |
| 2G Energy AG (2GB) | $146.19 Million | 16.19% | 0.90x | $344.59 Million |
| Star Micronics Co., Ltd. (2ZN) | $74.43 Billion | 2.49% | 0.25x | $572.39 Million |
| Arcure S.A. (340) | $8.25 Million | 21.18% | 1.54x | $10.75 Million |
| Valtecne S.p.A. (71W) | $10.98 Million | 20.94% | 1.55x | $8.28 Million |
| ENGIE Eps S.A (8XE) | $2.34 Million | -626.68% | 17.75x | $26.43 Million |
| FlexQube AB (publ) (A1Y) | $69.33 Million | -10.19% | 1.22x | $6.98 Million |
| Aalberts N.V (AACA) | $1.51 Billion | 13.52% | 0.92x | $3.32 Billion |
| WALTER MEIER AG NAM. (B4A1) | $169.51 Million | 12.55% | 0.87x | $155.45 Million |
| Biesse S.p.A (BI2) | $214.81 Million | 1.18% | 2.06x | $46.21 Million |
| STIF Société anonyme (D08) | $6.01 Million | 28.52% | 1.88x | $562.72K |